Opportunity Information: Apply for PAS 12 165
Apply for PAS 12 165
- The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Limited Competition Revision Applications to Advance Evidence Based Research Related to Protections for Human Subjects (U24)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs 93.307 Minority Health and Health Disparities Research 93.350 National Center for Advancing Translational Sciences 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.399 Cancer Control 93.865 Child Health and Human Development Extramural Research.
- This funding opportunity was created on May 9, 2012 and posted on Apr 20, 2012.
- Applicants must submit their applications by May 25, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $5,000,000.00 to eligible and selected applicants.
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Other Eligible Applicants include the following Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The funding opportunity PAS-12-165, titled "Limited Competition Revision Applications to Advance Evidence Based Research Related to Protections for Human Subjects (U24)," is a National Institutes of Health (NIH) discretionary grant program that uses a cooperative agreement mechanism (U24). In practical terms, this means NIH is not only providing funding but also expects substantial programmatic involvement as the supported work moves forward. The opportunity is specifically aimed at revision applications, not brand-new standalone awards, and it is limited in competition because it is intended for existing NIH-funded cooperative agreements that already support research networks or consortia. Those networks are expected to either be conducting research in the targeted areas now or to be positioned to do so in the near future.
The central goal of the announcement is to strengthen and expand evidence-based research on human subjects protections. Rather than treating research ethics and compliance as purely administrative requirements, this FOA emphasizes studying protections themselves as a topic of empirical research. The first major focus area is evaluating how effective current human subjects protections are in real-world research settings and developing tools and methods to examine and improve those protections as science changes. This includes building or refining approaches that can measure whether oversight systems (for example, IRB review processes, consent practices, monitoring approaches, or participant communication strategies) actually achieve their intended outcomes, such as minimizing risk, supporting informed decision-making, and maintaining public trust. The language about "evolving" approaches signals interest in protections that can adapt to modern research realities like large-scale data sharing, multi-site studies, pragmatic clinical trials, biobanking, and research that blends clinical care with data-driven discovery.
The second major focus area addresses a long-running and increasingly important question: what it would mean to require consent for research uses of deidentified human specimens and data. Traditionally, many regulations and policies have treated properly deidentified biospecimens and datasets as posing lower risk to individuals, often allowing certain types of research to proceed without specific consent. This FOA invites research that tests the feasibility, costs, benefits, and broader impacts of shifting that default, especially through newer consent models. The announcement explicitly mentions notification approaches and opt-out, opt-in, and broad consent models. Taken together, this suggests NIH was seeking rigorous evidence on questions such as: whether these consent models are workable at scale; how they affect participation rates and representativeness; what they cost institutions to implement; how they influence public attitudes and trust; whether they change the scientific value of resulting datasets; and whether they produce measurable improvements in participant understanding or autonomy without unintentionally harming equity or slowing valuable research.
From an administrative and eligibility standpoint, the opportunity is categorized under "Health, Income Security and Social Services" and ties to multiple CFDA programs, reflecting its cross-cutting relevance across NIH institutes and research domains. The estimated total funding amount listed is $5,000,000. There is no cost sharing or matching requirement, which means applicants are not expected to provide non-federal funds as a condition of award. The FOA was posted April 20, 2012, with an original and current closing date of May 25, 2012, and it was archived June 25, 2012, indicating it was a time-limited call.
Eligibility is constrained in two important ways. First, because this is a revision application to an existing cooperative agreement, only certain current awardees leading eligible networks/consortia would be positioned to apply, consistent with the "limited competition" framing. Second, foreign participation is restricted: non-U.S. entities (foreign institutions) are not eligible to apply, non-U.S. components of U.S. organizations are not eligible, and foreign components as defined by the NIH Grants Policy Statement are not allowed. In other words, this funding was intended to support domestic, U.S.-based infrastructure and collaborations for generating evidence on human subjects protections, rather than supporting work that would be formally carried out through foreign institutional components.
Overall, PAS-12-165 is best understood as a targeted NIH effort to upgrade the evidence base behind research ethics and oversight at a moment when biomedical and behavioral research practices were rapidly changing. By funding revisions to established networks and consortia, NIH was leveraging existing collaborative infrastructure to quickly generate empirical findings, practical tools, and tested methods that could inform policy and practice around consent, deidentification, participant rights, and the effectiveness of the systems designed to protect human subjects.
FAQs: NIH PAS-12-165 (U24) Limited Competition Revision Applications to Advance Evidence Based Research Related to Protections for Human Subjects
What is PAS-12-165?
PAS-12-165 is a National Institutes of Health (NIH) funding opportunity titled "Limited Competition Revision Applications to Advance Evidence Based Research Related to Protections for Human Subjects (U24)." It supports work that advances evidence-based research on human subjects protections.
What type of funding mechanism does this opportunity use?
This opportunity uses a cooperative agreement mechanism (U24). In a cooperative agreement, NIH provides funding and also expects substantial programmatic involvement as the supported work progresses.
Is this opportunity for new projects or revisions to existing awards?
It is specifically aimed at revision applications, not brand-new standalone awards. The competition is limited because it is intended for certain existing NIH-funded cooperative agreements that already support research networks or consortia.
Who is this opportunity intended for?
It is intended for existing NIH-funded cooperative agreement awardees that lead eligible research networks or consortia. These networks are expected to be conducting research in the targeted areas now or be positioned to do so in the near future.
What is the main goal of PAS-12-165?
The central goal is to strengthen and expand evidence-based research on human subjects protections. The announcement emphasizes studying protections themselves as an empirical research topic, rather than treating research ethics and compliance as purely administrative requirements.
What are the main focus areas of the funding opportunity?
The announcement describes two major focus areas: (1) evaluating the effectiveness of current human subjects protections in real-world research settings and developing tools and methods to examine and improve those protections as science changes; and (2) studying what it would mean to require consent for research uses of deidentified human specimens and data, including the feasibility and impacts of different consent models.
What kinds of human subjects protections does the FOA suggest studying?
The FOA points to oversight systems and practices such as IRB review processes, consent practices, monitoring approaches, and participant communication strategies, with an emphasis on whether these systems achieve outcomes like minimizing risk, supporting informed decision-making, and maintaining public trust.
Why does the FOA emphasize that protections need to be "evolving"?
The FOA signals interest in protections that can adapt to modern research realities, including large-scale data sharing, multi-site studies, pragmatic clinical trials, biobanking, and research that blends clinical care with data-driven discovery.
What does the FOA say about consent for deidentified specimens and data?
The FOA highlights a key question: what it would mean to require consent for research uses of deidentified human specimens and data. It invites research on the feasibility, costs, benefits, and broader impacts of shifting the default approach that has often allowed certain research uses of properly deidentified materials to proceed without specific consent.
What consent approaches are specifically mentioned?
The FOA explicitly mentions notification approaches and opt-out, opt-in, and broad consent models.
What kinds of questions does the FOA imply researchers should address about consent models?
Based on the description, NIH was seeking rigorous evidence on issues such as whether consent models are workable at scale, how they affect participation rates and representativeness, what they cost institutions to implement, how they influence public attitudes and trust, whether they change the scientific value of resulting datasets, and whether they improve participant understanding or autonomy without unintended harms such as reducing equity or slowing valuable research.
What is the estimated total funding amount for this opportunity?
The estimated total funding amount listed is $5,000,000.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement, meaning applicants are not expected to provide non-federal funds as a condition of award.
When was the FOA posted, and what were the closing dates?
The FOA was posted on April 20, 2012. The original and current closing date listed is May 25, 2012.
Is this funding opportunity still active?
No. The FOA was archived on June 25, 2012, indicating it was a time-limited call.
What category is this opportunity listed under?
It is categorized under "Health, Income Security and Social Services" and is tied to multiple CFDA programs, reflecting cross-cutting relevance across NIH institutes and research domains.
What are the key eligibility limitations?
Eligibility is constrained because it is a limited competition revision opportunity intended for certain existing NIH-funded cooperative agreements that support networks or consortia. Applicants would generally need to be current awardees in that category to be positioned to apply.
Are foreign institutions eligible to apply?
No. Non-U.S. entities (foreign institutions) are not eligible to apply.
Can a U.S. organization include a non-U.S. component or foreign component in the project?
No. Non-U.S. components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed.
What is the practical implication of the foreign participation restrictions?
The restrictions mean the funding was intended to support domestic, U.S.-based infrastructure and collaborations for generating evidence on human subjects protections, rather than supporting work formally carried out through foreign institutional components.
Why did NIH target revisions to established networks and consortia?
As described, NIH was leveraging existing collaborative infrastructure to more quickly generate empirical findings, practical tools, and tested methods that could inform policy and practice around consent, deidentification, participant rights, and the effectiveness of systems designed to protect human subjects.
Browse more opportunities from the same category: Health Income Security and Social Services
Next opportunity: Limited Competition Revision Applications to Advance Evidence Based Research Related to Protections for Human Subjects (U54)
Previous opportunity: Clinical Sequencing Exploratory Research (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAS 12 165
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAS 12 165) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Revision Applications to Advance Evidence Based Research Related to Protections for Human Subjects (U10) Apply for PAS 12 168 Funding Number: PAS 12 168 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Advanced Tools and Technologies for Cerebrospinal Fluid Shunts SBIR (R43/R44) Apply for PA 12 189 Funding Number: PA 12 189 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Advanced Tools and Technologies for Cerebrospinal Fluid Shunts STTR (R41/R42) Apply for PA 12 190 Funding Number: PA 12 190 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Global Network for Womens and Childrens Health Research (U10) Apply for RFA HD 13 006 Funding Number: RFA HD 13 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Data Coordinating Center for the NICHD Cooperative Multicenter Maternal Fetal Medicine Units Research Network (U10) Apply for RFA HD 13 013 Funding Number: RFA HD 13 013 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Data Coordinating Center for the NICHD Cooperative Multicenter Neonatal Research Network (U10) Apply for RFA HD 13 014 Funding Number: RFA HD 13 014 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| NICHD Research Short Courses (R25) Apply for PA 12 207 Funding Number: PA 12 207 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $125,000 |
| Juvenile Protective Factors and Their Effects on Aging (R01) Apply for PAR 12 218 Funding Number: PAR 12 218 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Reproductive Scientist Development Program (RSDP) K12 Apply for RFA HD 13 015 Funding Number: RFA HD 13 015 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Genetic and Genomic Analysis of Xenopus (R21) Apply for PAR 12 249 Funding Number: PAR 12 249 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Genetic and Genomic Analysis of Xenopus (R01) Apply for PAR 12 250 Funding Number: PAR 12 250 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Development of Mathematical Cognition and Reasoning and the Prevention of Math Learning Disabilities (R21) Apply for PA 12 246 Funding Number: PA 12 246 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Development of Mathematical Cognition and Reasoning and the Prevention of Math Learning Disabilities (R03) Apply for PA 12 247 Funding Number: PA 12 247 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $50,000 |
| Development of Mathematical Cognition and Reasoning and the Prevention of Math Learning Disabilities (R01) Apply for PA 12 248 Funding Number: PA 12 248 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54) Apply for RFA AR 13 012 Funding Number: RFA AR 13 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Cooperative Multicenter Reproductive Medicine Network (U10) Apply for RFA HD 13 016 Funding Number: RFA HD 13 016 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $200,000 |
| Global Partnerships for Social Science AIDS Research (R24) Apply for RFA HD 13 012 Funding Number: RFA HD 13 012 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
| Research Infrastructure for Demographic and Behavioral Population Science (R24) Apply for RFA HD 13 007 Funding Number: RFA HD 13 007 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $150,000 |
| Genomic Sequencing and Newborn Screening Disorders (U19) Apply for RFA HD 13 010 Funding Number: RFA HD 13 010 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: $1,250,000 |
| Human Heredity and Health in Africa (H3Africa) Collaborative Centers (U54) Apply for RFA RM 12 006 Funding Number: RFA RM 12 006 Agency: National Institutes of Health Category: Health Income Security and Social Services Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAS 12 165", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
